These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 9072554

  • 21. Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men.
    Takahashi H, Furusato M, Allsbrook WC, Nishii H, Wakui S, Barrett JC, Boyd J.
    Cancer Res; 1995 Apr 15; 55(8):1621-4. PubMed ID: 7712463
    [Abstract] [Full Text] [Related]

  • 22. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas.
    Shahnavaz SA, Bradley G, Regezi JA, Thakker N, Gao L, Hogg D, Jordan RC.
    Cancer Res; 2001 Mar 15; 61(6):2371-5. PubMed ID: 11289098
    [Abstract] [Full Text] [Related]

  • 23. [Deletion and down-regulation of mts1/p16 gene in human gastric cancer].
    Lu Y, Gao C, Cui J.
    Zhonghua Zhong Liu Za Zhi; 1996 May 15; 18(3):189-91. PubMed ID: 9387251
    [Abstract] [Full Text] [Related]

  • 24. Deletion analysis of the p16 tumour suppressor gene in phaeochromocytomas.
    Aguiar RC, Dahia PL, Sill H, Toledo SP, Goldman JM, Cross NC.
    Clin Endocrinol (Oxf); 1996 Jul 15; 45(1):93-6. PubMed ID: 8796144
    [Abstract] [Full Text] [Related]

  • 25. [Expression of CDKN2 gene product in human bronchogenic carcinoma].
    Jiang Y, Xia S, Dai X.
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr 15; 19(2):81-3. PubMed ID: 9388844
    [Abstract] [Full Text] [Related]

  • 26. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
    Shigemasa K, Hu C, West CM, Clarke J, Parham GP, Parmley TH, Korourian S, Baker VV, O'Brien TJ.
    J Soc Gynecol Investig; 1997 Apr 15; 4(2):95-102. PubMed ID: 9101469
    [Abstract] [Full Text] [Related]

  • 27. Abrogation of the p16-Rb pathway in Korean hepatocellular carcinomas.
    Lee TJ, Bae JJ, Lee JS, Lee SY, Kim HJ, Kim SK, Lee JY, Lee TY.
    Hepatogastroenterology; 2000 Apr 15; 47(36):1663-8. PubMed ID: 11149028
    [Abstract] [Full Text] [Related]

  • 28. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
    García-Castellano JM, Villanueva A, Healey JH, Sowers R, Cordon-Cardo C, Huvos A, Bertino JR, Meyers P, Gorlick R.
    Clin Cancer Res; 2002 Mar 15; 8(3):782-7. PubMed ID: 11895909
    [Abstract] [Full Text] [Related]

  • 29. Deletion analysis of the p16/CDKN2 gene in head and neck squamous cell carcinoma using quantitative polymerase chain reaction method.
    Rawnsley JD, Srivatsan ES, Chakrabarti R, Billings KR, Wang MB.
    Arch Otolaryngol Head Neck Surg; 1997 Aug 15; 123(8):863-7. PubMed ID: 9260553
    [Abstract] [Full Text] [Related]

  • 30. Molecular and immunohistochemical study of the inactivation of the p16 gene in primary hepatocellular carcinoma.
    Huang J, Shen W, Li B, Luo Y, Liao S, Zhang W, Cheng N.
    Chin Med J (Engl); 2000 Oct 15; 113(10):889-93. PubMed ID: 11775834
    [Abstract] [Full Text] [Related]

  • 31. [Alteration of p15 and p16 gene in gastric cancer].
    Fushida S, Yonemura Y, Kawamura T, Nojima N, Satoh T, Fujita H, Michiwa Y, Fujimura T, Nishimura G, Miwa K, Miyazaki I.
    Gan To Kagaku Ryoho; 1997 Jul 15; 24 Suppl 2():279-84. PubMed ID: 9263516
    [Abstract] [Full Text] [Related]

  • 32. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
    Lee CT, Capodieci P, Osman I, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C.
    Clin Cancer Res; 1999 May 15; 5(5):977-83. PubMed ID: 10353729
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens.
    Calvano JE, Rush EB, Tan LK, Rosen PP, Borgen PI, Van Zee KJ.
    Ann Surg Oncol; 1997 May 15; 4(5):416-20. PubMed ID: 9259969
    [Abstract] [Full Text] [Related]

  • 35. Absence of deletions but frequent loss of expression of p16INK4 in human ovarian tumours.
    Marchini S, Codegoni AM, Bonazzi C, Chiari S, Broggini M.
    Br J Cancer; 1997 May 15; 76(2):146-9. PubMed ID: 9231912
    [Abstract] [Full Text] [Related]

  • 36. p16INK4 gene mutation and allelic loss of chromosome 9p21-22 in Taiwanese hepatocellular carcinoma.
    Chen TC, Hsieh LL, Kuo TT, Ng KF, Wu Chou YH, Jeng LB, Chen MF.
    Anticancer Res; 2000 May 15; 20(3A):1621-6. PubMed ID: 10928081
    [Abstract] [Full Text] [Related]

  • 37. Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas.
    Marchetti A, Buttitta F, Pellegrini S, Bertacca G, Chella A, Carnicelli V, Tognoni V, Filardo A, Angeletti CA, Bevilacqua G.
    J Pathol; 1997 Feb 15; 181(2):178-82. PubMed ID: 9120722
    [Abstract] [Full Text] [Related]

  • 38. Absence of p16/MTS1 gene mutations in human prostate cancer.
    Chen W, Weghorst CM, Sabourin CL, Wang Y, Wang D, Bostwick DG, Stoner GD.
    Carcinogenesis; 1996 Dec 15; 17(12):2603-7. PubMed ID: 9006095
    [Abstract] [Full Text] [Related]

  • 39. High frequency of homozygous deletion and methylation of p16(INK4A) gene in oral squamous cell carcinomas.
    Nakahara Y, Shintani S, Mihara M, Ueyama Y, Matsumura T.
    Cancer Lett; 2001 Feb 26; 163(2):221-8. PubMed ID: 11165758
    [Abstract] [Full Text] [Related]

  • 40. Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas.
    Esteve A, Martel-Planche G, Sylla BS, Hollstein M, Hainaut P, Montesano R.
    Int J Cancer; 1996 May 03; 66(3):301-4. PubMed ID: 8621247
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.